• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal

tetano

Editor, Senior Moderator
PLoS One


. 2022 Aug 10;17(8):e0272636.
doi: 10.1371/journal.pone.0272636. eCollection 2022.
Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal


Sangam Shah[SUP] 1 [/SUP], Shreeyash Raj Bhattarai[SUP] 1 [/SUP], Kriti Basnet[SUP] 1 [/SUP], Yagya Raj Adhikari[SUP] 2 [/SUP], Tara Ballav Adhikari[SUP] 3 4 5 [/SUP], Nikita Bhatta[SUP] 6 [/SUP], Rajan Chamlagain[SUP] 2 [/SUP], Susan Aryal[SUP] 2 [/SUP], Sanjit Kumar Sah[SUP] 2 [/SUP], Govinda Bhandari[SUP] 2 [/SUP], Bibek Bhandari[SUP] 7 [/SUP], Sujan Poudel[SUP] 8 [/SUP], Pankaj Pant[SUP] 9 [/SUP], Santa Kumar Das[SUP] 9 [/SUP]



Affiliations

Abstract

Introduction: The post-coronavirus disease 2019 (COVID-19) syndrome is defined as the persistence of symptoms after viral clearance and the emergence of new symptoms after a few months following recovery from COVID-19. This study aimed to assess the prevalence of post-COVID-19 syndrome and the risk factors that contribute to its development.
Methods: This study was conducted prospectively in Tribhuvan University Teaching Hospital (TUTH), located in Maharajgunj, Kathmandu. The patients were followed up for three months.
Results: The post-COVID status of 300 patients admitted to the COVID emergency of TUTH was studied. The mean age of the patients was 46.6±15.7 years, and the proportion of male (56%) was slightly higher than female (44%). Most of the patients (81.7%) had fever on their presentation to the emergency which was followed by fatigue (81.3%) and cough (78.3%). During the post-COVID phase, fatigue was the most common persistent symptom, with 34% experiencing fatigue after 60 days and 28.3% even after 90 days from the onset of symptoms. Univariate logistic regression showed sore throat (OR 4.6; 95% CI (2.8-7.6)), rhinitis (OR 3.6; 95% CI (2.1-5.9)), fatigue (OR 3.7; 95% CI (1.8-7.6)), diarrhea (OR 4.1; 95% CI (2.4-6.9)), anosmia (OR 6.7; 95% CI (3.9-11.3)), ageusia (OR 7.8; 95% CI (4.5-13.4)) and shortness of breath (OR 14.9; 95% CI (1.8-119.6)) at admission were all predictors of post-COVID syndrome after three months.
Conclusion: Even after recovering from COVID-19, people with COVID-19 may develop symptoms. As a result, COVID-19's long-term consequences should not be neglected, as they may lead to increased morbidity among patients, consumption of financial resources, and added burden on the health system.
 
Back
Top Bottom